MSLP

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/18/2017
Contact Info
  • 4721 Ironton Street
  • Building A
  • Denver, CO 80239

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
CIK 0001415684
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2006
Employees 85 a/o Dec 31, 2016
Company Officers/Contacts
Ryan Drexler Interim CEO
Peter Lynch CFO
Jena Sellers Director, Financial Reporting
Douglas West Controller
Company Directors
Ryan Drexler Chairman
Michael Doron
Service Providers
Investment Bank
GVC Capital LLC
5350 South Roslyn Street
Suite 400
Greenwood Village, CO, 80111
United States
 
Accounting/Auditing Firm
Ehrhardt Keefe Steiner & Hottman PC
7979 E. Tufts Ave
Suite 400
Denver, CO, 80237
United States
 
Securities Counsel
SRFF LLP
61 Broadway
New York, NY, 10006
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Tone in Twenty until 3-2010
MSLP Security Details
Share Structure
Market Value1 $33,102,300 a/o Mar 24, 2017
Authorized Shares 100,000,000 a/o Mar 22, 2017
Outstanding Shares 15,763,000 a/o Mar 22, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 11,674,260 a/o Mar 22, 2017
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Corporate Stock Transfer, Inc.
Shareholders
Shareholders of Record 326 a/o Mar 22, 2017
Short Selling Data
Short Interest 196,779 (3.77%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security